Drugs / polyvalent antigen-KLH conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00693342 | — | fallopian tube cancer, ovarian cancer, peritoneum cancer | Gynecologic Oncology Group | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polyvalent antigen-KLH conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00693342 ↗ |
| Modality | Vaccine | “polyvalent antigen-KLH conjugate vaccine” NCT00693342 ↗ |